Phibro Animal Health Corp. (PAHC) Upgraded to “Buy” by TheStreet
Several other analysts also recently commented on PAHC. Zacks Investment Research upgraded Phibro Animal Health Corp. from a strong sell rating to a hold rating in a research note on Tuesday, July 12th. Credit Suisse Group AG restated a buy rating and issued a $29.00 target price on shares of Phibro Animal Health Corp. in a research note on Tuesday, August 30th. Morgan Stanley set a $23.00 target price on Phibro Animal Health Corp. and gave the company a sell rating in a research note on Sunday, September 4th. Finally, Guggenheim set a $30.00 target price on Phibro Animal Health Corp. and gave the company a buy rating in a research note on Monday, September 12th. Three investment analysts have rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the company. Phibro Animal Health Corp. has an average rating of Hold and an average target price of $30.67.
Phibro Animal Health Corp. (NASDAQ:PAHC) traded up 0.18% on Friday, hitting $27.23. The stock had a trading volume of 154,213 shares. Phibro Animal Health Corp. has a 52 week low of $16.80 and a 52 week high of $35.69. The company has a 50-day moving average price of $24.59 and a 200-day moving average price of $22.05. The stock has a market capitalization of $1.07 billion, a price-to-earnings ratio of 13.15 and a beta of 1.34.
Phibro Animal Health Corp. (NASDAQ:PAHC) last posted its quarterly earnings data on Monday, August 29th. The company reported $0.40 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.38 by $0.02. Phibro Animal Health Corp. had a return on equity of 105.21% and a net margin of 11.02%. The firm earned $189.20 million during the quarter. During the same period last year, the business posted $0.44 earnings per share. The business’s revenue was up 2.3% on a year-over-year basis. Equities research analysts anticipate that Phibro Animal Health Corp. will post $1.41 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Wednesday, September 28th. Shareholders of record on Wednesday, September 7th were paid a dividend of $0.10 per share. The ex-dividend date was Friday, September 2nd. This represents a $0.40 dividend on an annualized basis and a yield of 1.47%. Phibro Animal Health Corp.’s dividend payout ratio (DPR) is currently 19.42%.
A number of institutional investors have recently added to or reduced their stakes in PAHC. RidgeWorth Capital Management LLC bought a new position in Phibro Animal Health Corp. during the second quarter worth about $24,107,000. Thornburg Investment Management Inc. increased its position in Phibro Animal Health Corp. by 20.8% in the second quarter. Thornburg Investment Management Inc. now owns 1,327,077 shares of the company’s stock worth $24,763,000 after buying an additional 228,171 shares during the period. BlackRock Fund Advisors increased its position in Phibro Animal Health Corp. by 8.5% in the second quarter. BlackRock Fund Advisors now owns 1,468,069 shares of the company’s stock worth $27,394,000 after buying an additional 115,056 shares during the period. JPMorgan Chase & Co. increased its position in Phibro Animal Health Corp. by 50,493.1% in the second quarter. JPMorgan Chase & Co. now owns 109,281 shares of the company’s stock worth $2,039,000 after buying an additional 109,065 shares during the period. Finally, FMR LLC increased its position in Phibro Animal Health Corp. by 29.3% in the second quarter. FMR LLC now owns 413,329 shares of the company’s stock worth $7,713,000 after buying an additional 93,729 shares during the period. Institutional investors and hedge funds own 47.88% of the company’s stock.
About Phibro Animal Health Corp.
Phibro Animal Health Corporation is an animal health and mineral nutrition company. The Company is engaged in developing, manufacturing and marketing products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. The Company operates through three segments: Animal Health, Mineral Nutrition and Performance Products.
Receive News & Stock Ratings for Phibro Animal Health Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corp. and related stocks with our FREE daily email newsletter.